A prospective study of leukocyte telomere length and risk of renal cell carcinoma

Cancer Epidemiology Biomarkers and Prevention

Volumn 22, Issue 5, 2013, Pages 997-1000

  Hofmann, Jonathan N ^a   Lan, Qing ^a   Cawthon, Richard ^b   Hosgood III, H Dean ^c   Shuch, Brian ^a   Moore, Lee E ^a   Rothman, Nathaniel ^a   Chow, Wong Ho ^d   Purdue, Mark P ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^c ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^d UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA;

ADULT; AGED; BLOOD SAMPLING; CANCER DIAGNOSIS; CANCER RISK; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HUMAN; KIDNEY CARCINOMA; LEUKOCYTE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REVIEW; RISK ASSESSMENT; TELOMERE HOMEOSTASIS;

ADULT; AGED; CARCINOMA, RENAL CELL; CASE-CONTROL STUDIES; FEMALE; HUMANS; KIDNEY NEOPLASMS; LEUKOCYTES; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RISK FACTORS; TELOMERE;

EID: 84877995215     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-13-0142     Document Type: Review

References (8)

1. Wentzensen IM, Mirabello L, Pfeiffer RM, Savage SA. The association of telomere length and cancer: A meta-analysis. Cancer Epidemiol Biomarkers Prev 2011;20:1238-50.
2. Wu X, Amos CI, Zhu Y, Zhao H, Grossman BH, Shay JW, et al. Telomere dysfunction: A potential cancer predisposition factor. J Natl Cancer Inst 2003;95:1211-8.
3. Shao L, Wood CG, Zhang D, Tannir NM, Matin S, Dinney CP, et al. Telomere dysfunction in peripheral lymphocytes as a potential predisposition factor for renal cancer. J Urol 2007;178(4 Pt 1): 1492-6.
4. Hofmann JN, Baccarelli A, Schwartz K, Davis FG, Ruterbusch JJ, Hoxha M, et al. Risk of renal cell carcinoma in relation to blood telomere length in a population-based case-control study. Br J Cancer 2011;105:1772-5.
5. Hayes RB, Reding D, Kopp W, Subar AF, Bhat N, Rothman N, et al. Etiologic and early marker studies in the prostate, lung, colorectal and ovarian (PLCO) cancer screening trial. Control Clin Trials 2000;21(6 Suppl):349S-55S.
6. Cawthon RM. Telomere length measurement by a novel monochrome multiplex quantitative PCR method. Nucleic Acids Res 2009;37:e21.
7. Lan Q, Cawthon R, Shen M, Weinstein SJ, Virtamo J, Lim U, et al. A prospective study of telomere length measured by monochrome multiplex quantitative PCR and risk of non-Hodgkin lymphoma. Clin Cancer Res 2009;15:7429-33.
8. Shen M, Cawthon R, Rothman N, Weinstein SJ, Virtamo J, Hosgood HD, et al. A prospective study of telomere length measured by monochrome multiplex quantitative PCR and risk of lung cancer. Lung Cancer 2011;73:133-7.